AAD: Study Examines Incidence of Non-Melanoma Skin Cancer

This article originally appeared here.
Share this content:
AAD: Study Examines Incidence of Non-Melanoma Skin Cancer
AAD: Study Examines Incidence of Non-Melanoma Skin Cancer

FRIDAY, March 20, 2015 (HealthDay News) -- The incidence of non-melanoma skin cancer (NMSC) is much higher for Caucasians than Hispanics or Asians, but Hispanic patients are significantly younger than Caucasian or Asian patients, according to research presented at the annual meeting of the American Academy of Dermatology, held from March 20 to 24 in San Francisco.

Tiffany Loh, from the University of California, San Diego, School of Medicine, and colleagues compared the incidence of NMSC among Hispanic, Asian, and Caucasian patients in a five-year retrospective chart review. Data were included for 4,029 cases of NMSCs.

The researchers found that 96.3 percent of patients were Caucasian, 2.9 percent Hispanic, and 0.8 percent Asian. Hispanic patients were significantly younger (average age, 62.1 years) than Caucasians (average age, 66.6 years; P = 0.003) and Asians (average age, 70.3 years; P = 0.023). Among Caucasians, most NMSCs occurred in men (64 percent), while for Hispanics and Asians, more cases occurred in females (66.1 and 60.6 percent, respectively).

"The rise of NMSCs in Hispanics and Asians, especially among women, is concerning given that they are the fastest growing ethnic populations in the United States. Proper photoprotection counseling should be stressed to minorities to prevent further increase of NMSC," the authors write. "Future large multi-center studies focusing on NMSC features (not only those indicated for Mohs micrographic surgery) and risk factors among minorities are necessary to further elucidate our findings."

Abstract
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »